These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19442131)

  • 1. Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients.
    Sternfeld T; Lorenz A; Schmid M; Schlamp A; Demmelmair H; Koletzko B; Bogner JR
    Curr HIV Res; 2009 May; 7(3):336-9. PubMed ID: 19442131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
    Milazzo L; Piazza M; Sangaletti O; Gatti N; Cappelletti A; Adorni F; Antinori S; Galli M; Moroni M; Riva A
    J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.
    ter Hofstede HJ; Willems HL; Koopmans PP
    J Clin Virol; 2004 Jan; 29(1):44-50. PubMed ID: 14675869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.
    Feeney ER; Mallon PW
    Curr Pharm Des; 2010 Oct; 16(30):3339-51. PubMed ID: 20687890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study.
    Geené D; Sudre P; Anwar D; Goehring C; Saaïdia A; Hirschel B
    J Infect; 2000 Mar; 40(2):160-3. PubMed ID: 10841093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
    Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
    Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.
    Miller RF; Shahmonesh M; Hanna MG; Unwin RJ; Schapira AH; Weller IV
    Antivir Ther; 2003 Jun; 8(3):253-7. PubMed ID: 12924544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
    Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
    Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].
    Sergerie M; Martinet S; Kiffer N; Teulé R; Pasquier C; Bujan L
    Gynecol Obstet Fertil; 2004 Oct; 32(10):841-9. PubMed ID: 15501159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mitochondrial dysfunction in circulating peripheral blood lymphocytes from HIV-infected people.
    Polo R; Martinez S; Madrigal P; Gonzalez-Muñoz M
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):32-6. PubMed ID: 14501790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms.
    Nolan D; Mallal S
    Antivir Ther; 2004 Dec; 9(6):849-63. PubMed ID: 15651744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
    Moyle G
    Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Sharma PL; Nurpeisov V; Hernandez-Santiago B; Beltran T; Schinazi RF
    Curr Top Med Chem; 2004; 4(9):895-919. PubMed ID: 15134548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
    Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
    Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients].
    Llibre-Codina JM; Casado-Gómez MA; Sánchez-de la Rosa R; Pérez-Elías MJ; Santos-González J; Miralles-Alvarez C; Martínez-Chamorro E; Domingo-Pedrol P; Alvarez-García ML; Moreno-Guillén S
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):98-107. PubMed ID: 17288907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
    Kohler JJ; Lewis W
    Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    Maagaard A; Kvale D
    J Antimicrob Chemother; 2009 Nov; 64(5):901-9. PubMed ID: 19740910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.